[Hypertension management in France: where are we now?]

Hypertension management in france: where are we now? Hypertension remains the most common chronic disease in France. Its management, which has demonstrated its effectiveness on the occurrence of cardiovascular, renal and cognitive complications, is therefore of major interest for public health. Nevertheless, the results of the Esteban study conducted in 2015 show that the management of hypertension in France has not improved significantly since 2006, date of the last study conducted on a representative sample of the French population. In 2015, one in three adults was hypertensive in France. If the level of screening of hypertension remained high in France with more than 80% of adults who reported having had a blood pressure measurement in the year, about one in two hypertensives was not aware of its hypertension. Fewer than one in two hypertensives were pharmacologically treated and only one in two adults had a controlled blood pressure, less than 25% of all hypertensives. The situation has even deteriorated in women with a significant decrease in the use of pharmacological treatments. Adherence to antihypertensive therapy remained very low with only 64% of the days of the year covered by treatment. More than 40% of hypertensive patients had, in 2015, a home blood pressure monitor. The situation in France, particularly the level of awareness of hypertension among patients, remains below the levels observed in other european countries. There is an urgent need for effective action on this first step to significantly improve the management of hypertension in France. Finally, it seems necessary to understand the reasons for the significant decline in the proportion of women treated pharmacologically to avoid a potential loss of chance harmful to the health of these women.